Literature DB >> 17359320

Dependence of correlations between antibody titres and opsonophagocytosis on pneumococcal serotype and patient morbidity in pre- and post-pneumococcal vaccination states.

D Tarragó1, L Aguilar, W T M Jansen, M J Giménez, A Avellón, J J Granizo, J Casal.   

Abstract

Pre- vs. post-vaccination changes in correlations between IgG concentrations (ELISA titres) and opsonophagocytic activity (OPA) against Streptococcus pneumoniae serotypes 6B, 14 and 23F induced by the 23-valent polysaccharide vaccine were studied in paired serum samples received from elderly individuals, haemodialysed patients and kidney transplant recipients by the Spanish Pneumococcal Reference Laboratory. The pre- and post-vaccination parameters considered were: ELISA and OPA titres and the percentage of subjects with post-vaccination OPA values above the cut-off levels; the correlations between OPA and ELISA (Spearman correlation coefficient, r); and the amount of IgG needed to obtain OPA (beta coefficient). Non-significant pre-vaccination correlations between OPA and ELISA were found. Vaccination increased the correlation coefficient between OPA and ELISA to a statistically significant level for serotypes 6B, 14 and 23F in samples from haemodialysed patients, for serotypes 14 and 23F in samples from elderly individuals, and for none of the serotypes in samples from transplant recipients. In all cases, except for serotype 23 in transplant recipients, vaccination increased the beta coefficient, indicating that lower amounts of IgG were needed to obtain high OPA titres. A globally lower response was obtained for serotype 23 and/or transplant recipients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17359320     DOI: 10.1111/j.1469-0691.2006.01677.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  5 in total

1.  Serotype-specific anti-pneumococcal IgG and immune competence: critical differences in interpretation criteria when different methods are used.

Authors:  Anne Balloch; Paul V Licciardi; Mimi L K Tang
Journal:  J Clin Immunol       Date:  2012-09-30       Impact factor: 8.317

Review 2.  Pneumococcal Capsular Polysaccharide Immunity in the Elderly.

Authors:  Hugh Adler; Daniela M Ferreira; Stephen B Gordon; Jamie Rylance
Journal:  Clin Vaccine Immunol       Date:  2017-06-05

3.  A Nonfunctional Opsonic Antibody Response Frequently Occurs after Pneumococcal Pneumonia and Is Associated with Invasive Disease.

Authors:  Fabian Uddén; Jonas Ahl; Nils Littorin; Kristoffer Strålin; Simon Athlin; Kristian Riesbeck
Journal:  mSphere       Date:  2020-02-05       Impact factor: 4.389

4.  Durability of Antibody Response after Primary Pneumococcal Double-Dose Prime-Boost Vaccination in Adult Kidney Transplant Recipients and Candidates: 18-Month Follow-Up in a Non-Blinded, Randomised Clinical Trial.

Authors:  Lykke Larsen; Claus Bistrup; Søren Schwartz Sørensen; Lene Boesby; Charlotte Sværke Jørgensen; Christian Nielsen; Isik Somuncu Johansen
Journal:  Vaccines (Basel)       Date:  2022-07-07

5.  Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients.

Authors:  Per Nived; Göran Jönsson; Bo Settergren; Jon Einarsson; Tor Olofsson; Charlotte Sværke Jørgensen; Lillemor Skattum; Meliha C Kapetanovic
Journal:  Arthritis Res Ther       Date:  2020-02-22       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.